News #Sickle cell disease


Article including C2C work on important German newspaper

Article including C2C work on important German newspaper

A description of the journey of a family with a child with sickle cell disease who emigrated from Togo to Germany.

Read More  
C2C on Lancet Haematology

C2C on Lancet Haematology

C2C contributed to an article on Sickle Cell Disease treatment in the prestigious medical journal Lancet Haematology.

Read More  
Breakthrough for thalassemia and sickle cell disease presented at the 2020 meeting of the American Society of Hematology

Breakthrough for thalassemia and sickle cell disease presented at the 2020 meeting of the American Society of Hematology

On Sunday December 6 2020, Dr. Haydar Frangoul from Tristar Children's Hospital, Nashville, TN, USA, presented preliminary results of gene editing for the cure of Thalassemia and sickle cell disease.

Read More  
C2C pivotal in European BMT group position paper

C2C pivotal in European BMT group position paper

Our experience in BMT services set up in middle income countries drives European Blood and Marrow Transplantation group stand on the approach to the cure of pediatric disorder in reduced resources settings..

Read More  
BMT start-up in Armenia

BMT start-up in Armenia

First allogeneic transplant in Armenia

Read More